US UK Tax Returns Preparation for a Vet Practice Sale
By US-UK Tax Advisors cross-border tax team · Last updated OCT 29, 2026

Selling your practice company to a corporate buyer as a US citizen in the UK? How the UK and US returns treat cash, deferred payments and rollover shares.
Key Takeaways
- Covers cross-border tax for US-UK cross-border taxpayers
- Applies to US persons with UK ties and UK residents with US income
- Highlights the filing, reporting and tax-treaty points to check
- Get personalised advice before acting on your own facts
US UK tax returns preparation for a vet practice sale comes down to one problem: HMRC and the IRS tax the same sale of your practice company, but they recognise different parts of the price in different years, and the US foreign tax credit only works if those years line up. A US-citizen veterinary surgeon living in the UK pays UK Capital Gains Tax on the shares, possibly at the Business Asset Disposal Relief rate, and also reports the gain to the IRS, because US citizens are taxed on worldwide income. Done well, you pay roughly the higher of the two taxes. Done badly, you pay both, or pay one country years before the credit can be used in the other.
Corporate buyers rarely pay in a single cheque. The usual package is cash at completion, a deferred or earn-out element over one to three years, and often rollover equity in the buyer's holding group, and each piece is treated differently by each country. In the returns we prepare for US-citizen practice owners, the failure mode we see most often is not a missed relief; it is a UK tax bill that lands in a US tax year with no matching gain, so the credit sits unused while the US tax has already been paid.
What does a vet practice sale look like for a US citizen in the UK?
Most UK practices sold to corporate buyers are run through a private limited company owned by one or more clinical directors, and the buyer acquires the shares. A share sale is the starting assumption for this guide; asset sales are covered later.
For a US citizen, the practice company is a foreign corporation. That means there has probably been an annual Form 5471 for every year you held a significant stake, the gain is a capital gain on foreign corporate stock rather than a pass-through gain, and the US anti-deferral rules may have touched the company's profits for years. If you co-own with UK partners who are not US persons, the company may not be a controlled foreign corporation at all, which simplifies the history but not the final-year reporting.
How is the sale taxed in the UK?
A UK-resident seller pays Capital Gains Tax on the gain on the shares: the proceeds less the base cost, which for a founder is often only the nominal value of the subscriber shares. For individuals, GOV.UK's published rates for shares are 18% for gains that fit within any unused basic rate band and 24% above it. Most practice owners are higher-rate taxpayers in the year of sale, so the 24% rate is the one that applies to gains outside Business Asset Disposal Relief.
Business Asset Disposal Relief is a UK relief that taxes qualifying business gains at a reduced rate up to a lifetime limit. GOV.UK at https://www.gov.uk/business-asset-disposal-relief sets out the rate by date of disposal: 10% on or before 5 April 2025, 14% between 6 April 2025 and 5 April 2026, and 18% from 6 April 2026. The lifetime limit is £1 million of gains, according to https://www.gov.uk/business-asset-disposal-relief/how-to-claim, and anything you have claimed on an earlier disposal counts against it. For share disposals, the conditions must be met throughout the two years up to the sale:
- You are an employee or office holder of the company, or of a company in the same group. A clinical director normally satisfies this without difficulty.
- The company's main activities are trading, or it is the holding company of a trading group; a large cash pile or let property can put this at risk.
- The company is your personal company: at least 5% of the shares and voting rights, plus at least 5% of either distributable profits and assets on a winding up, or sale proceeds.
- The claim is made through Self Assessment or Section A of the BADR helpsheet by the first anniversary of the 31 January after the tax year of sale; for 2025 to 2026, GOV.UK gives 31 January 2028.
How does the IRS tax the same sale?
On the US return the sale is a disposition of stock in a foreign corporation, reported on Form 8949 and Schedule D. The gain is measured in dollars: proceeds at the exchange rate on the date of sale, less your dollar basis at the rate when you acquired the shares. With shares subscribed at nominal value, the US and UK gains look similar in size but never match exactly once exchange rates and timing enter.
Shares held for more than a year produce a long-term capital gain, taxed at the preferential US rates. On top sits the Net Investment Income Tax. The IRS explains at https://www.irs.gov/individuals/net-investment-income-tax that it is a 3.8% tax on the lesser of net investment income or the excess of modified adjusted gross income over $250,000 for married filing jointly, $125,000 for married filing separately and $200,000 for single filers, computed on Form 8960. A gain on corporate shares is investment income even if you worked in the practice every day.
The NIIT is where sellers expect the UK tax to protect them and find it does not. The IRS treats the NIIT as outside the ordinary foreign tax credit rules, and its Form 8960 instructions do not allow a deduction for foreign tax already claimed as a credit. Treaty-based relief is a contested filing position, so in the returns we prepare we model the NIIT as a real cost unless a disclosed position is taken knowingly.
Can the foreign tax credit absorb the UK tax on the share sale?
In principle, yes. UK Capital Gains Tax is a creditable foreign income tax, and because UK rates on a practice sale are at or above US long-term capital gain rates, a well-matched credit usually removes the regular US tax on the gain. Two points decide whether it works.
The first is source. The foreign tax credit cannot reduce US tax on US-source income; IRS Publication 514 at https://www.irs.gov/publications/p514 says so plainly. Gains on shares are sourced largely by the seller's residence and tax home, with special rules for US citizens abroad that look at whether meaningful foreign tax is paid on the gain. Where part of the gain would stay US-source, the US-UK treaty's double-taxation article can re-source it, and Publication 514 lists income re-sourced by treaty as a separate limitation category on Form 1116, which cannot be pooled with your UK taxes on salary or dividends.
The second is timing, which is the gap that almost none of the published guidance on selling a UK company addresses for US sellers. The UK tax year runs from 6 April to 5 April. Under the US rules for taxpayers who claim foreign taxes on the accrual basis, which is the usual election for US citizens in the UK, a foreign tax is generally treated as accruing when the foreign tax year closes. A sale completed between 6 April and 31 December therefore produces a US gain in that calendar year, but the UK tax for that UK year accrues in the following calendar year, because the UK year does not end until the next 5 April. The credit and the gain land on different US returns.
The fix is the one-year carryback. Publication 514 explains that unused foreign taxes are first carried back to the preceding year and then forward for up to 10 years. In practice you file the year-of-sale return with the gain fully taxed, pay the US tax, and amend that return once the UK tax accrues. On a large sale that is substantial cash parked with the IRS for a year or more, and it belongs in the completion cash-flow plan.
Does the month of completion change the US UK tax returns preparation?
It changes it more than any other single variable, and it is usually agreed by lawyers without anyone looking at the US side. The decision table below is the one we use when a client tells us a completion date is being negotiated:
- If completion falls between 1 January and 5 April, then the gain and the UK tax accrual fall in the same US year, and the credit can normally go on the original return.
- If completion falls between 6 April and 31 December, then the UK tax accrues in the next US year, so plan on paying the US tax first and recovering it through a carryback and amended return.
- If completion falls on or after 6 April 2026, then BADR gains are taxed at 18% rather than 14%, which raises the UK tax and therefore the creditable amount, but does not change the US tax on the gain.
- If part of the price is deferred and the US installment method applies, then map each payment to its UK tax year and its US year separately.
- If you convert the sterling proceeds to dollars after the sale date, then expect a separate US foreign currency gain or loss in the year of conversion.
How are deferred and earn-out payments handled on each return?
The UK splits deferred consideration into two kinds. A fixed sum payable on a set date is ascertainable: it is included in the proceeds at completion and taxed in the tax year of sale, before you receive it, with some relief if it later proves irrecoverable. An earn-out tied to future revenue or profit is unascertainable: the UK taxes the market value of the right at completion, and later receipts are disposals of that right, with their own gains or losses that do not automatically carry Business Asset Disposal Relief. That is a point for the share purchase agreement, not the return.
The US approach is different. IRS Publication 537 at https://www.irs.gov/publications/p537 defines an installment sale as a sale where at least one payment is received after the tax year of the sale, and the installment method lets you report the gain as payments arrive. It is the default unless you elect out, and the election is made by the due date, including extensions, of the return for the year of sale. Shares in a private practice company are not traded on an established market, so the bar on using the installment method for publicly traded stock does not apply. Earn-outs with no fixed price are contingent payment sales, which have their own basis-recovery rules in the installment regulations.
Put the two together and the mismatch is plain. A fixed deferred payment is taxed by the UK in year one and by the US in the year it is paid. Electing out of the installment method pulls the US gain forward to sit alongside the UK tax, at the price of paying US tax on cash not yet received. There is no universal answer; we run both versions before the first return is filed, because the election cannot normally be revoked without IRS consent.
What happens to rollover equity in the buyer's group?
Rollover equity is the part of the price paid in shares of the buyer's holding company instead of cash. Buyers like it because it keeps the selling vet invested in the group's performance. On the UK side, an exchange of shares for shares in the acquiring company can qualify for share-for-share treatment: no disposal is treated as taking place for the rolled portion, and the new shares take over the base cost and acquisition date of the old ones. The UK gain on that part is deferred until the new shares are sold, typically when the buyer's group is itself sold or refinanced.
The US side should not be assumed to follow. US nonrecognition rules for reorganisations and for contributions to a corporation the contributors control each carry structural requirements. Some reorganisations require solely voting stock as consideration, which a mix of cash, deferred payments and shares often fails, and a single selling vet rarely controls the receiving company. Whether a rollover qualifies depends on the buyer's structure, so we review the transaction documents, not the heads of terms.
Where the UK defers but the US taxes the rollover now, the US gain on those shares has no UK tax to credit in the year of sale. UK tax arrives only when the new shares are sold, perhaps four or five years later and well beyond the one-year carryback window, so it may go unused unless other foreign-source income absorbs it. This is the most expensive mismatch in a practice sale for a US citizen, and it should be priced into how much equity you roll.
Is a share sale different from a sale of the practice's goodwill and assets?
Yes, materially. If the buyer purchases the goodwill, premises and equipment from the company, the gain arises inside the company first and bears UK Corporation Tax, and the cash must then be extracted by dividend or liquidation and taxed again in your hands. For a US shareholder, a gain realised by a foreign corporation can also reach your US return through the anti-deferral regimes reported on Form 5471 before any cash is distributed, depending on the company's status and the character of the gain. Sole traders and partnerships are different again: the gain is personal from the outset and the US treats each asset separately.
Which US information returns are due in the year of sale?
The year of sale is usually the final year of Form 5471 reporting for the practice company, and it carries more disclosure than an ordinary year. The IRS instructions at https://www.irs.gov/instructions/i5471 describe Category 3 filers as including a US person who disposes of enough stock in a foreign corporation to reduce their interest below the 10% threshold of vote or value. Category 3 filers complete Schedule O, Part II, which reports acquisitions and dispositions of the stock. If you owned more than 50% by vote or value, you are also a Category 4 filer; a sole owner of a controlled foreign corporation who meets both Category 4 and Category 5a checks Category 4 only and completes the full form. Form 5471 is attached to your income tax return and filed by its due date, including extensions.
- Form 5471 for the practice company for its final period under your ownership, including Schedule O, Part II for the disposition.
- Form 8949 and Schedule D for the gain on the shares, and Form 6252 for any part of the price reported on the installment method.
- Form 1116, with the share gain in the category the sourcing analysis supports, usually the treaty re-sourced category, plus carryback workings where the UK tax accrues in the next year.
- Form 8960 for the Net Investment Income Tax.
- FBAR and Form 8938 for the UK account that receives the completion money, whose year-end balance is often far above anything reported before.
- Form 5471 for the buyer's holding company only if your rollover stake reaches the 10% threshold, which is uncommon but not unheard of in smaller deals.
Does converting the sale proceeds into dollars create a separate US gain?
It can. Once proceeds arrive in sterling, those pounds are a nonfunctional currency for US purposes, with a dollar basis equal to their value on receipt. Converting or spending them later produces a foreign currency gain or loss. Under 26 USC 988, at https://www.law.cornell.edu/uscode/text/26/988, that gain or loss is computed separately and treated as ordinary, not capital. The exception for an individual's personal transactions, with a de minimis rule covering gains of $200 or less, does not reach transactions connected with producing income or managing investment property, so we document the purpose of a proceeds account at the time.
The UK does not tax this movement, because the proceeds were sterling from the start. A US currency gain is US tax with no UK credit; a currency loss is an ordinary loss that can be valuable against other income.
Worked illustration: a 50% stake sold in July 2026
The figures below are an illustration only, not a real client. Dr K is a US citizen, UK resident, higher-rate taxpayer and owns 50% of a practice company alongside a UK co-owner who is not a US person. Her shares have negligible base cost and she has never claimed Business Asset Disposal Relief. The sale completes on 15 July 2026, in the UK tax year 2026 to 2027. Her £3,000,000 share is £2,200,000 cash at completion, a fixed £400,000 deferred payment due July 2027, and £400,000 of rollover shares. We assume $1.30 to £1 at completion and $1.25 to £1 when she converts the cash in November 2026.
- UK gain taxed for 2026 to 2027: £2,600,000, being the cash plus the ascertainable deferred payment. The rollover shares are deferred under share-for-share treatment, assuming the conditions are met.
- UK tax: £1,000,000 at the 18% BADR rate is £180,000; the remaining £1,600,000 at 24% is £384,000; total £564,000, ignoring the annual exempt amount for simplicity.
- US 2026 gain: the £2,200,000 cash at $1.30 is $2,860,000. The deferred £400,000 is reported on the installment method in 2027. Assuming, to show the risk, that the US taxes the rollover, a further $520,000 arises in 2026, giving $3,380,000.
- Credit timing: the UK year 2026 to 2027 closes on 5 April 2027, so the £564,000 accrues in US year 2027. The 2026 US return is filed with no credit for it, and the US tax on $3,380,000 is paid in full.
- Recovery: in 2027 the UK tax on the cash portion is carried back to 2026 by amended return, and the tax on the deferred payment is matched to the 2027 installment gain. None of it relates to the rollover shares, so the US tax on the $520,000 has no UK credit now.
- Currency: converting £2,200,000 at $1.25 yields $2,750,000 against a $2,860,000 basis, a $110,000 foreign currency loss, ordinary in character if the account falls outside the personal-transaction exception.
- NIIT: 3.8% applies to the US gain above her threshold, and in our modelling it is a cost the UK tax does not reduce.
Change one assumption, a completion date of 15 March 2026 instead of July, and the picture moves. The UK year 2025 to 2026 closes on 5 April 2026, so the UK tax accrues in the same US year as the gain and the carryback disappears. But the BADR portion is then taxed at 14% rather than 18%, so the UK bill is lower and less US tax is covered by credit. The completion date should be chosen with both returns in view.
What is the step-by-step order of work after completion?
This is the sequence we follow once the deal has signed. Order matters, because several US elections are made on the first return.
- Collect the share purchase agreement, completion statement, earn-out schedule and rollover documents, and confirm the completion date.
- Record the exchange rate on the completion date and on every later payment date, and keep bank statements showing when sterling was converted.
- Classify each piece of the price for the UK, as cash, ascertainable deferred, unascertainable earn-out or share exchange, and confirm the BADR conditions and claim.
- Classify each piece for the US, including the installment method or election out, contingent payment treatment and whether the rollover qualifies for nonrecognition.
- Map every UK tax amount to its UK tax year and the US year it accrues in, and flag credits to carry back or forward.
- Prepare the final-year Form 5471 with Schedule O, Part II, alongside Form 8949, Form 6252, Form 1116 and Form 8960.
- Report the new completion account balances on the FBAR and Form 8938, and diarise the amended US return once the UK tax is fixed.
What should a US-citizen vet settle before signing heads of terms?
Most of the cost in these sales is locked in before any return is prepared: the completion date, the split between cash, deferred payments, earn-out and equity, and shares versus assets. The buyer has no reason to care about your US position, so bringing a quantified view of the NIIT, the credit timing and the rollover exposure into the negotiation early is what separates a sale with near-zero US tax from one without.
We prepare the UK Self Assessment return, the US federal return and the information returns together, so the same exchange rates, payment dates and character decisions run through both. If earlier Form 5471 or FBAR filings were missed, bring that history into compliance before the sale reporting goes in.
Related reading and tools
- US Tax Services & IRS Compliance
- UK Tax Services
- IRS Streamlined Filing
- UK Income Tax Calculator
- US Federal Income Tax Calculator
Every situation is different. Book a cross-border tax consultation to discuss how these rules apply to you.
Authoritative sources
IRS — Streamlined Filing Compliance Procedures
FinCEN — Report of Foreign Bank and Financial Accounts (FBAR)
GOV.UK — Tax on foreign income
IRS — Foreign Earned Income Exclusion



